Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No.20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, Aurobindo Pharma has submitted the Integrated Filing (Financial) for the quarter and nine months period ended December 31, 2024. The aforesaid Integrated Filing (Financial) is also being updated on the website of the Company at https://www.aurobindo.com/.